Related Experiment Video
Updated: Apr 20, 2026
07:34
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
3.3K
The gut microbiota and inflammatory bowel disease
Katsuyoshi Matsuoka1, Takanori Kanai
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinano-machi, Shinjuku, Tokyo, 160-8582, Japan.
Seminars in Immunopathology
|November 26, 2014
Summary
Inflammatory bowel disease (IBD) involves gut inflammation. Research shows IBD patients have reduced bacterial diversity and altered gut bacteria, suggesting microbiota plays a role in disease development and treatment.
Area of Science:
- Gastroenterology
- Microbiology
- Immunology
Background:
- Inflammatory bowel disease (IBD) is a chronic gut inflammation with unknown causes.
- Current hypotheses suggest environmental factors trigger immune responses in genetically susceptible individuals, involving gut microbiota.
- Next-generation sequencing reveals significant alterations in gut microbiota composition in IBD patients.
Purpose of the Study:
- To explore the role of gut microbiota dysbiosis in the pathogenesis of inflammatory bowel disease.
- To summarize consistent findings regarding gut microbiota alterations in IBD.
- To discuss the potential of microbiota-targeted therapies for IBD.
Main Methods:
- Review of next-generation sequencing studies identifying gut microbiota alterations in IBD.
- Analysis of consistent dysbiosis patterns across various studies.
- Examination of IBD susceptibility genes related to bacterial recognition.
Main Results:
- Consistent findings in IBD include reduced bacterial diversity, decreased Firmicutes, and increased Proteobacteria.
- Dysbiosis is implicated in IBD pathogenesis, supported by IBD susceptibility genes.
- Therapies aimed at correcting dysbiosis show promise for IBD treatment.
Conclusions:
- Gut microbiota dysbiosis is a significant factor in inflammatory bowel disease.
- Targeting gut microbiota alterations offers potential therapeutic strategies for IBD.
- Further research is needed to fully elucidate the mechanisms linking dysbiosis to intestinal inflammation.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
16
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
16
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
19
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
19
01:26Inflammatory Bowel Disease I: Introduction
21
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
21
01:17Irritable Bowel Syndrome I: Introduction
1.5K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.5K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.6K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.6K
01:18Functions of the Gut Microbiota
115
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
115